CLL MRD Flow Panel

Code
FLG-CLMR-03BX
Panel
Active-Compendium
88184(x1), 88185(x7). Add 88187(x1) for global.
Clinical
Oncology,Pathology
<p>Bone marrow aspirate: 2-3 mL EDTA preferred. Sodium heparin is acceptable.<br/>
Peripheral blood: 5-6 mL EDTA preferred. Sodium heparin is acceptable.<br/>
NY Clients: Please provide Date and Time of Collection.<br/>
Note: Lithium heparin or ACD (pale yellow/no gel separator) is not acceptable. Please provide recent CBC report.</p>
Flag Active
True
Orderable Test Description
Available as global test only. Markers are CD3, CD5, CD19, CD20, CD22, CD43, CD79b, CD81 (8 markers).
Orderable Turn Around Time
24 Hours
Meta Description
Available as global test only. Markers are CD3, CD5, CD19, CD20, CD22, CD43, CD45, CD79b, and CD81 (9 markers). The CLL MRD Flow Panel follows the strategy developed by the European Research Initiative in CLL (ERIC) and can detect minimal residual disease at the 0.01% level.
Orderable Biomarkers
NY Approved
True
Orderable Biomarkers JSON
{"Flow Cytometry": {"Markers": ["CD3", "CD22", "CD58", "CD20", "CD81", "CD43", "CD79b", "CD19"]}}
Keywords string
ERIC, residual disease CLL MRD Flow Panel
Title URL
cll-mrd-flow-panel
Storage and transportation
Specimens should be received at NeoGenomics within 72 hours from collection to assure sample integrity and acceptable cell viability. Note: New York State samples must be received within 48 hours from collection per NYS requirements. Refrigerate specimen. Do not freeze. Use cold pack for transport, making sure cold pack is not in direct contact with specimen.